Where Tech Meets Bio
Latest News
NVIDIA has released a new AI-driven workflow, the Biomedical AI-Q Research Agent Developer Blueprint, designed to accelerate the early phases of drug discovery by automating …
Read More
Nabla Raises $70M Series C to Expand Agentic AI Platform for Clinical Workflows
Nabla, developer of a widely adopted AI assistant used by over 130 healthcare organizations, has raised a $70 million Series C round led by HV …
Read More
Axiom Bio Releases Human Liver Toxicity Dataset with 130,000 Compounds to Advance AI-based Toxicity Prediction
San Francisco-based startup Axiom Bio, previously backed by $15 million in seed funding from investors including Amplify Partners, Dimension Capital, and Zetta Ventures, has released …
Read More
Latest News
Xaira Publishes Largest Public Perturb-seq Atlas to Advance Virtual Cell Modeling
Agenus and Noetik Partner to Develop AI-Based Biomarkers Using Virtual Cell Models
Isomorphic Labs Appoints Ben Wolf as Chief Medical Officer, Expands to U.S. Hub in Cambridge
Ryght AI Raises $3M to Automate Clinical Trial Site Activation with Agentic AI
AstraZeneca Signs $5.3B AI Drug Discovery Deal with CSPC for Chronic Disease Programs
Insilico Medicine Completes Oversubscribed Series E, Bringing Total Funding to $123 Million
Latest Insights
by Bea Mann, PhD
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
In recent years, therapeutic capabilities in oncology have grown dramatically, with a vast array of advanced treatments progressing through clinical trials and onto the market. …
Read More
by BiopharmaTrend
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying strategic trends for drug developers …
Read More
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
by Adele Ruder, Alexander Hustinx, Louise von Stechow
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
From Our Partners
Sponsored by
SpiroChem
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
Sponsored by
Lantern Pharma
Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Partner Events

The 12th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link

Interactive Response Technologies 2025
Event Date: Oct. 14, 2025 - Oct. 15, 2025
Location: United States of America (The Westin Copley Place, Boston, MA)
Website: Link
Promo Code: IRT25BPT
Read more ›››

RNA Leaders USA Congress
Event Date: Sept. 10, 2025 - Sept. 11, 2025
Location: United States of America (Boston Exhibition & Convention Center)
Website: Link
Promo Code: MMBioPharmaTrend15
Read more ›››
Case Studies
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Interviews
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma
[Interview] How D-Wave Brings Quantum Computing Into Biology
The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández
Most Read
5 AI-Powered Companies Transforming the Future of Fertility Care
The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing
10 Companies Applying AI for Biologics Discovery
Six AI-driven Drug Discovery Companies Enabling Precision Oncology